Parkinson's disease and parkinsonism Flashcards

1
Q

Movement disorders - where is the problem in ‘pyramidal’ or ‘upper motor neurone’ disorder? what does this result in?

A

Problems with corticospinal/pyramidal tract

Pyramidal weakness 

Spasticity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Movement disorders - where is the problem in hyperkinetic movement disorder?

A

problem in the basal ganglia

Dystonia 

Tics 

Myoclonus 

Chorea 

Tremor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

movement disorders - where is the problem in hypokinetic movement disorder?

A

parkinsonism

-lack of dopamine in the basal ganglia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ataxia - where is the problem?

A

cerebellum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the aetiology of parkinson’s disease?

A

sections through brainstem reveals loss of the normally dark pigment in the substantia nigra and locus coeruleus

pigment loss correlates with dopaminergic cell loss 

neurohistological landmark of PD are Lewy bodies

usually an asymmetric disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
Describe the tremor in parkinson's disease
-what is it like?
-what does it affect?
-when is it present?
-
A

Involuntary, repetitive, rhythmic sinusoidal movement usually affecting one or more limbs

Primarily affects hands, may involve upper/lower limbs, less frequently jaw and lips, never head or neck 

Pill-rolling in the hands, or finger flexion-extension or abduction/adduction 

Present at rest, exacerbated by anxiety or stress 

Improves/disappears on action 

Typically reappears after few sec when arms held outstretched 

Tremor frequency in low to mid range (3-6hz) with varying amplitude 

Can observe tremor while patient is focused on a particular mental task e.g. counting backward
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the rigidity in parkinson’s disease

  • what is it like?
  • what is cogwheel rigidity?
  • how can rigidity be accentuated?
A

Increase in muscle tone in parkinson’s disease is relatively constant throughout the range of movement: lead pipe rigidity

No increase with higher mobilising speed (distinguishing it from spasticity) 

Cogwheel rigidity is a consequence of the tremor of parkinsons disease being superimposed on background of lead-pipe rigidity 

Rigidity in one arm can be accentuated by asking the patient to lift and lower the contralateral arm repeatedly at the same time 

Positive froments manouvre
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the bradykinesia found in parkinson’s disease

  • what is it like?
  • what is micrographia
  • how can lack of spontaneous movement manifest?
A

Slowness of movement with progressive loss of amplitude or speed during attempted rapid alternating movement of body segments

Assessed by foot tapping/opening and closing hand, quickly and widely as poss. 

Particular difficulty with complex motor tasks (micrographia) 

Smaller hand writing 

Lack of spontaneous movement nay manifest: 

Poverty facial expression/mask-like face and eye-blinking - hypomimia 

Difficulty changing position 

Quiet/monotonous speech - hypophonia 

Abnormal gait and stance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the gait seen in parkinson’s disease

  • posture
  • what is particularly difficult?
  • what are steps like?
A

Flexed or stooped posture

In some cases extreme anterior truncal flexion - camptocormia 

Unable to maintain a normal stance in response to pressure  

Initiation of walking may be difficult – freezing 

Turning may be difficult 

Patients may use trick such as deliberately stepping over a walking stick to change direction 

Steps are small and shuffling 

Normal arm swing on walking is lost 

Festination – very fast succession of steps and difficulty stoppping
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Other motor symptoms in parkinsons disease:

  • what kind of gaze is difficult?
  • what is difficult to do in the GI system?
  • is there any MSK manifestations?
  • is muscle power/reflexes/sensations/plantar response affected?
A

Mild impairment of upgaze, eyelid tremor

Difficulty swallowing, including saliva 

Many patients have a frozen shoulder 

Muscle power/reflexes/sensations/plantar response is normal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the non-motor symptoms found in parkinson’s disease? 7

A

Depression – chemical depression

Visual hallucinations – esp. at night 

Psychosis – worsening hallucinations and delusions may escalate 

Dementia – common feature of advanced parkinsons, >80% of pt.s after 20years 

Insomnia 

Autonomic symptoms – greasy skin, constipation, bladder disturbance, erectile dysfunction 

Anosmia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Parkinson’s disease epidemiology:

  • is it common?
  • male to female?
  • what increases the probability of a genetic cause?
A

Second most common neurodegenerative disorder after AD

!- 2% over 60- 65’s affected 

0.3% population 

male to female 3:2 

annual incidence rates 8.6-19 per 1000 

due to ageing population, prevalence and socioeconomic burder expected to rise exponentially 

early onset (below 40years) increases probability of genetic cause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the risk factors for parkinson’s disease?

A

old age = strongest risk factor

28 distinct chromosomal regions have been linked to PD 

6 of these contain genes that conclusively cause monogenetic PD 

monogenetic PD accounts for 30% familial and 3-5% sporadic cases 

pesticide exposure and +ve FH are other risk factors 

possible protective role of NSAIDs and high uric acid levels 

smoking has a protective affect

therefore etiology is genetically heterogeneous and multifactorial – genes, modifying effects by susceptible alleles and environmental factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Should you see sensory/pyramidal/cerebellar signs in parkinson’s disease?

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the investigations for parkinsons disease?

A

To rule out treatable conditions of asthenia: hypothyroid, anaemia

Structural brain imaging 

Possibly dopamine functional imaging 

PET with fluoro-dopa (limited avail. And high cost) 

DAT-SPECT 

These are unable to distinguish PD from other causes of parkinsonism, but should be normal in essential tremor, dystonic tremor, psychogenic parkinsonism 

Positive levodopa challenge (or s.c. apomorphine) 

Genetic testing if appropriate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are common causes of parkinsonism? 6

A
  • drug-induced/iatrogenic parkinsonism (prochloperazine, metoclopramide, antipsychotics, severe calcium channel blockers, amiodarone, chloroquine)
  • progressive supranuclear palsy
  • multi system atrophy – parkinsonism
  • dementia with lewy bodies
  • diffuse white matter ischaemia/vascular parkinsonism
  • lower half parkinsonism with marked gait apraxia
17
Q

Describe drug induced parkinsonism

A

Any drug that bocks action of dopamine esp. neuroleptic drugs

symmetrical 

coarse postural tremor 

presence of other drug induced disorders 

orolingual dyskinesias, tardive dystonia, akathisia 

series of events important: emergence of symptoms after drug exposure 

improvement/resolutions within a few mths of complete withdrawal of drug
18
Q

what is progressive supranuclear palsy?

A

Symmetric akinetic-rigid syndrome with predominantly axial involvement

Gait and balance impairment (early falls) 

Tremor is infrequently seen in these patients 

Vertical gaze supranuclear palsy 

Pseudobulbar symptoms 

Retrocollis 

Continuous activity of the frontalis muscle with eyes wide open (staring) 

Frontal-subcortical cognitive deficits 

No response to levo-dopa 

Some patients may also present with parkinsonism (PSP-parkinsonism)
19
Q

what is multi system atrophy?

A

Common cause of degenerative parkinsonism

Age of onset 6th/7th decade 

Core triad: dysautonomia (atonic bladder/postural hypotension), cerebellar features and parkinsonism 

Jerky postural tremor, pyramidal signs (generalised hyperreflexia and extensor plantar responses) 

Sub-optimal and short-lived levodopa response in 1/3 pts. 

Other suggestive features: 

Severe dysarthria or dysphonia 

Marked antecollis 

Inspiratory sighing 

Orofacial dystonia 

MRI may show cerebellar and pontine atrophy (hot cross bun sign or hypertense rim surrounding theputamen in T2-weighted sequences
20
Q

What is dementia with lewy bodies?

A

Dementia is predominant feature

Daily fluctuations in alertness and cognition 

Visual hallucinations (colourful, often involving human figures) 

Extreme sensitivity to neuroleptic medication 

Dysautonomia 

Controversial as to whether this is a separate disease entity
21
Q

What is vascular parkinsonism?

A

affects predominantly lower limbs

rest tremor uncommon 

other signs of brain vascular lesions might be present – spasticity/hemiparesis/pseudobulbar palsy 

poor levodopa response 

structural brain imaging guides diagnosis
22
Q

Describe an essential tremor:

-what does it respond to?

A

symmetrical, postural or kinetic tremor with higher frequency (up to 12Hz)

infrequently observed at rest 

often autosomal dominant inheritance with mean onset 15yrs 

alcohol responsiveness 

head tremor – if present – mild
23
Q

What is SWEDDs?

A

(scans without evidence of dopaminergic deficit)

Often rest and asymmetrical tremor but no true bradykinesia 

Clinical and electrophysiological characteristics of dystonia
24
Q

Describe the principles of treatment of parkinson’s disease?

A

Delay treatment until onset of disabling features and then initiate treatment.

Initial maintenance dose of levodopa should start with 50mg TDS and not exceed 600mg/day

All other agents for the treatment of motor symptoms can be combined with levodopa to reduce end of dose deterioration and the on-off syndrome
25
Q

Why is levodopa used with a decarboxylase inhibitor?

-side effects of levodopa?

A

usually combined with a decarboxylase inhibitor (e.g. carbidopa or benserazide) to prevent peripheral metabolism of levodopa to dopamine

reduced effectiveness with time (usually by 2 years)

unwanted effects: dyskinesia (involuntary writhing movements), ‘on-off’ effect, dry mouth, anorexia, palpitations, postural hypotension, psychosis, drowsiness

no use in neuroleptic induced parkinsonism

26
Q

What are dyskinesias/’wearing off’ and on-off effects in relation to levodopa?

A

Dyskinesia are involuntary movements occurring in association with drug treatment, e.g. twisting/turning movements when dopamine levels are high (peak-dose dyskinesia)

Wearing off is when individual doses only produce short lived affects 

On-off is where the patient switches from symptomatic benefit of medication (on) to an akinetic-rigid state often without any predictable relationship to the timing of drug doses
27
Q

What other drugs exist for the treatment of motor symptoms in parkinson’s disease?

A

Dopamine agonists:

  • Ergot derivatives: bromocriptine, pergolide, di-hydroergocryptine
  • Non-ergot derivatives: ropinirole, pramipexole, rotigotine, apomorphine

Catechol-O-methyltransferase inhibitor (entacapone, tolcapone)

Amantadine

MAO-B inhibitors

Antimuscarinics

28
Q

What are ergot derivative dopamine agonists assoc. with? what does this mean for initiation of this treatment?

A

ergot-derived dopamine receptor agonists (bromocriptine, cabergoline, pergolide*) have been associated with pulmonary, retroperitoneal and cardiac fibrosis. The Committee on Safety of Medicines advice that an echocardiogram, ESR, creatinine and chest x-ray should be obtained prior to treatment and patients should be closely monitored

29
Q

What side effects are assoc. with all dopamine agonists?

A

patients should be warned about the potential for dopamine receptor agonists to cause impulse control disorders and excessive daytime somnolence

more likely than levodopa to cause hallucinations in older patients. Nasal congestion and postural hypotension are also seen in some patient

30
Q

What is the role of COMT inhibitors in parkinson’s disease?

A

e.g. Entacapone, tolcapone
COMT is an enzyme involved in the breakdown of dopamine, and hence may be used as an adjunct to levodopa therapy
used in conjunction with levodopa in patients with established PD

31
Q

What is the role of amantadine in parkinsons disease?

A

mechanism is not fully understood, probably increases dopamine release and inhibits its uptake at dopaminergic synapses
side-effects include ataxia, slurred speech, confusion, dizziness and livedo reticularis

32
Q

How do MAOB inhibitors help treat parkinson’s disease?

A

e.g. Selegiline

inhibits the breakdown of dopamine secreted by the dopaminergic neurons

33
Q

When are anti-muscarinics used to treat parkinsonism?

A

block cholinergic receptors

now used more to treat drug-induced parkinsonism rather than idiopathic Parkinson’s disease
help tremor and rigidity
e.g. procyclidine,

benzotropine, trihexyphenidyl (benzhexol)